The replacement of a single anterior maxillary tooth is predictably achieved using endosseous dental implants.
1,2 Recent investigations have extended reported outcomes from implant survival data to include important information about esthetic outcomes using objective scoring of soft tissues (pink esthetic score or PES 3 ) and supported crowns. 4 In addition, interest is emerging about patient-based outcomes related to satisfaction. 5 Several systematic reviews indicate high implant survival and shortterm esthetic success associated with high patient satisfaction.
The replacement of a failing or missing anterior tooth may be a consequence of trauma, caries, periodontal disease, or anodontia. The clinical presentation of the tooth or the residual alveolar ridge strongly influences the procedural course of therapy, and different protocols, including immediate placement and provisionalization, immediate provisionalization, early placement, or conventional placement in healed alveolar ridges, have been advocated. Several investigators reported that high implant survival and esthetic success may be achieved for either immediate placement with provisionalization or immediate provisionalization of implants placed in healed ridges. 6, 7 An early placement protocol has been alternatively advocated. 4, 8 In the anterior maxillary alveolar ridge, the local conditions for esthetic implant placement and restoration are often unfavorable because of multiple architectural factors. 9 Irrespective of the clinician's preference, when considering implant placement into extraction sockets or alveolar ridges, there will be situations when bone grafting is required.
Alveolar bone grafting and socket preservation procedures are commonly performed, and many different methods for bone augmentation have been evaluated. The use of autogenous bone, allogeneic bone substitutes, and recombinant osteoinductive agents with or without occlusive membranes have been illustrated and are supported by case series. When considering prospective, comparative studies, Esposito et al 10 concluded that there was little data to distinguish the outcomes of one or another material or technique. In a separate review 11 it was concluded that there is merit in selecting procedures that are simpler and less invasive, involve less risk of complications, and reach their goals most expeditiously. A recent systematic review suggested that adequate alveolar bone augmentation may be achieved using particulate xenograft or allograft materials beneath barrier membranes. 12 Following healing and initial consolidation of the grafted alveolar ridge, the eventuality of implant placement can be met by different clinical approaches that include two-stage, one-stage, and immediate provisionalization protocols. Expedited therapies often appeal to patients. When implants cannot be placed in extraction sockets or healed ridges and bone augmentation is required, the subsequent placement of the implant may be achieved using an immediate provisionalization procedure. The outcomes of immediate provisionalization of implants placed into recently grafted bone have not been fully investigated. As part of a larger, prospective study of immediate provisionalization of implants placed in extraction sockets and healed ridges, several patients required bone grafting to support future implant placement. Here, the 5-year outcome of immediately provisionalized implants placed in recently grafted bone is reported. Implant survival, marginal bone level, and soft tissue architectural changes were evaluated.
Method and materials
This data is a subset of data representing patients enrolled in a fourcenter investigation comparing immediate placement and provisionalization with immediate provisionalization of maxillary implants in the esthetic zone. The details of this investigation are reported elsewhere. 6, 13 According to an institutional review board-approved protocol, 139 patients were recruited for implant placement. At the time of surgery, anatomical or volumetric conditions that precluded implant placement for immediate placement and/or provisionalization were identified in 21 patients. A guided bone regeneration (GBR) procedure was performed using anorganic bovine bone (Bio-Oss, Geistlich) and a resorbable collagen membrane (Bio-Gide or BioMend, Geistlich). Primary closure was obtained, and the sites were left to heal for a period of 4 to 6 months, after which implant placement was performed.
Implant placement and restoration
Briefly, following uneventful healing of the grafted alveolus, 3.5-to 5.0-mm wide and 11-to 17-mm long implants (OsseoSpeed, Dentsply) were placed under local anesthesia using a modified protocol. Preoperative analgesics (eg, 800 mg ibuprofen) and antibiotics (1 g amoxicillin or 600 mg clindamycin) were prescribed. Transmucosal punches were used for flapless access in the majority of cases; however, conventional flaps were performed in seven of the patients. Osteotomies were created to depth but undersized with respect to diameter (3.2-mm diameter for 3.5-and 4.5-mm implants or 3.7-mm diameter for 4.0-and 5.0-mm implants). For 4.5-and 5.0-mm implants, conical tapered drills were required. The stability of the implant was visually and tactilely assessed at the time of placement. Immediate provisionalization procedures were performed using Direct Abutment or Profile BiAbutment (Dentsply) and acrylic crowns. Abutments were placed with finger pressure (approximately 15 to 20 Ncm). The crowns were adjusted to be free of centric or eccentric contacts. A periapical radiograph was taken to (1) evaluate implant placement, (2) ensure abutment placement, (3) discover residual cement, and (4) serve as a baseline for evaluation of marginal bone level changes. Postoperative prescriptions for analgesics, antimicrobial mouthrinse (0.12% chlorhexidine gluconate), and antibiotics (amoxicillin 500 mg, three times daily for 5 to 7 days) were given to all patients. Instructions for oral hygiene included the maintenance of conventional toothbrushing and flossing, with local restrictions around the provisional crown for the first 7 to 10 days. Eight weeks after implant, abutment, and provisional crown placement, the provisional crown was removed, and the abutment was retightened to 25 Ncm. An impression was taken of the abutment, and a definitive all-ceramic (Procera [Nobel Biocare] or Lava [3M Espe]) crown was fabricated using conventional prosthodontic procedures. At 11 to 12 weeks, the definitive crown was cemented, and a periapical radiograph was taken.
Follow-up evaluation
Individuals were evaluated at 26 weeks and annually for 5 years following provisional crown placement. The initial clinical treatment and follow-up evaluation are illustrated longitudinally in Fig 1. Implant immobility was assessed clinically. Implant failure was indicated by pain, peri-implant radiolucency, and/or mobility. Abutment and crown complications and failures were recorded. Plaque and bleeding scores were recorded at four points for each crown (mesiolingual, distolingual, mesiobuccal, and distobuccal). The gingival zenith score (linear distance from the gingival zenith to the incisal edge reference) and the papilla score (linear distance from the papilla tip to the incisal edge reference of adjacent tooth) were recorded to the nearest 0.5 mm. Periapical radiographs were taken by a long cone paralleling technique at implant placement, definitive crown cementation, and at 6 months and yearly for the 5-year follow-up period (Fig 2) . A radiologist, independent from the group of investigators, performed all the radiographic interpretations. The distance of the mesial and distal interproximal bone to the reference point (the outer aspect of the implant bevel) was measured to the nearest 0.1 mm. A mean of these two measurements was calculated for each implant, and the changes from baseline, ie, implant placement, were calculated for each subsequent time point.
Statistical analysis
Descriptive statistics were used in analyzing patient group and implant characteristics. A nonparametric test, Wilcoxon signed rank test, was used to analyze differences between visits or time intervals in terms of hard and soft tissue parameters. The level of significance was set at 0.05 for each test.
Results
Among the 21 patients, 19 had 23 implants placed with primary stability that were included in this 5-year evaluation. Two implants did not achieve primary stability, were not immediately provisionalized, and therefore were not included in the subsequent analyses. Of the 23 implant sites, 16 were placed in sites developed from extraction sockets and 7 were placed in augmented healed ridges. After the 4-to 6-month graft healing period, 23 implants were placed with acceptable primary stability and were restored with provisional crowns.
The study cohort included 7 women (mean ± SD age: 41 ± 19 years) and 12 men (mean ± SD age: 39 ± 16 years). Among these, all were nonsmokers, with three reporting previous tobacco use. The bone quality estimates included 9 (39%) type 2 and 12 (52%) type 3. Bone quantity was high (91% types A and B). No canine sites were represented among the patients; the 23 implants were widely distributed among incisor and premolar sites (Table 1) . One implant was determined to be mobile at the time of definitive crown impression (67 days following placement) and was removed. One implant was lost to follow-up after the 6-month evaluation as a result of patient relocation. The calculated implant survival at 5 years was 95.6%. In this study, the relationship of the reference point (the outer aspect of the implant bevel) to the interproximal crest at implant placement was reported by the investigator as supracrestal (concave), crestal (flat), or subcrestal (convex) and was most frequently flat (20/23) , indicating that clinicians achieved crestal implant placement. Marginal bone levels were measured from implant placement to 5 years. The position of the average marginal bone level (mesial and distal) over the 5-year follow-up period is presented in Table 2. As noted, the marginal bone levels were stable over the 5 years. The mean ± SD marginal bone level change after 5 years was -0.18 ± 0.79 mm (range: -1.6 to 1.4 mm). The distribution of marginal bone level changes is presented in Fig 3. Half of the sites (9/18) recorded no bone loss or bone gain, while only four sites displayed more than 1 mm of interproximal marginal bone loss after 5 years.
The affiliated peri-implant coronal plaque and bleeding indices were consistently 15% or lower ( Table 3 ). The direct intraoral measurement of papillae revealed the increased interproximal dimension of approximately 1 mm within the first year following implant and crown placement. This increase in interproximal soft tissue remained throughout the 5-year period (Table  4) . Regarding the buccal soft tissues, the direct measurement of the distance from the incisal edge to the peri-implant mucosal zenith demonstrated minor reductions (mean ± SD tissue growth: 0.24 ± 0.93 mm) in this dimension over the 5-year period (Table 5) . When comparing the change in the peri-implant mucosal zenith location for implants placed in grafted bone using a flapped versus flapless procedure, minor tissue recession occurred at implants placed using flaps (−0.21 mm ± 1.07) versus flapless procedures (+0.46mm ± −0.80). 
Discussion
This study evaluated implant survival and peri-implant tissue response following immediate provisionalization of implants placed into recently grafted alveolar ridges and sockets. After a healing period of 4 to 6 months following augmentation using demineralized bovine bone mineral and a collagen barrier membrane, sufficient bone was available for placement of implants with primary stability in the majority of patients. However, initial primary stability was not achieved for 2 of 25 implants planned for the 21 patients. The immediate provisionalization of the implants resulted in one early implant loss without late failures and produced high implant survival after a 5-year follow-up period (95.6%). In the related prospective study comparing immediate provisionalization of implants placed into ungrafted sockets or healed ridges, the same high implant survival (96%) was recorded at 3 years. 13 In a systematic review of alveolar augmentation and implant placement, Jensen and Terheyden 14 indicated that several combinations of bone grafting materials and procedures permit implant placement and are associated with high implant survival. In another review, 15 it was concluded that bone grafting procedures as performed in this study are effective in promoting augmentation in postextraction sites. The authors concluded that survival rates over 95% may be expected for both immediate and early placement. The present investigation is in agreement with this review regarding implant survival and tissue stability associated with later implant placement. However, the related study involving immediate placement and provisionalization also demonstrated the same magnitude of tissue stability, calling in question the fundamental causes of tissue stability and the potential reasons for tissue instability. 16 The stated risk factors of thin tissue biotype, facial malposition of the implant, and a thin or damaged facial bone wall were averted by the present grafting of deficient alveolar ridges or sockets.
Jung et al 17 reported on the comparison of implant placement in alveolar ridges augmented using demineralized bovine bone allograft and collagen membranes with or without recombinant human bone morphogenetic protein 2. None of the 34 implants in 11 patients were lost in either grafting situation; there were insignificant changes in the marginal bone levels over the 5-year evaluation period. In a related work, Benic´ et al 18 demonstrated 100% implant survival for implants in concomitantly grafted bone and 94.1% implant survival for implants placed in native alveolar bone. They concluded that implants placed with concomitant bone regeneration did not perform differently from implants placed into native bone with respect to implant survival, marginal bone height, and peri-implant soft tissue parameters. The osseointegration of implants does not appear to be negatively impacted by the presence of healed or healing demineralized bone allograft. This may reflect the relative abundance of native alveolar bone supporting the implant and/or the integrity of the osseointegration process within regenerated bone. Importantly, the present study did not include any canine sites (or traumatically avulsed teeth), which may have required more significant alveolar reconstruction that could challenge optimal esthetic outcomes.
There is sufficient histologic evidence that titanium implants are integrated within regenerated bone. Bone-to-implant contact is not negatively impacted by the presence of residual xenograft or allograft particles in the augmented sites. In a canine model, implants placed in deproteinized bovine bone mineral (DBBM; BioOss) 3 months after grafting showed equivalent osseointegration to implants placed in healed ridges following a 4-month healing period. 19 In a primate model, osseointegration within tissues regenerated using DBBM and a collagen membrane was confirmed. 20 In a surgical defect model in dogs, histology revealed that DBBM grafts placed around implants at placement resulted in a normal range of boneto-implant contact (30% to 40%). At 4 months, however, some of the newly formed bone resorbed. 21 Bio-Oss exhibited osteo conductive properties and was recommended for GBR procedures in dehiscence defects with respect to vertical and horizontal growth of bone. Norton et al 22 illustrated that the new bone volume created by augmentation procedures using this method was approximately 25% vital bone (with approximately 25% residual matrix), and this tissue supported the successful osseointegration of dental implants (97%).
It should be noted that some controversy remains regarding the value of graft material to the process of osseointegration at subsequent implant placement. In a canine buccal defect model, it was concluded that significant bone-to-implant contact was not achieved at DBBMgrafted sites. 23 In a recent consideration of the bone-to-implant contact achieved at microimplants placed into grafted sinuses, Browaeys et al 24 concluded that osseointegration in sinus bone grafts mixed with BioOss was poor. This result may not be limited to the type of material: SpinNeto et al 25 indicated similar limitations in osseointegration achieved clinically using an allogeneic bone graft. Rasmusson et al 26 directly compared the implant stability and survival of implants placed in grafted maxillary bone and intact maxillary bone and found no difference in implant performance. In the present scenario, the high implant survival may reflect that much of the implant was placed in native alveolar bone. Clinical alveolar regeneration and subsequent dental implant osseointegration can be achieved using the protocol utilized in this study.
The present investigation involved a relatively brief healing period of 4 to 6 months following augmentation. There is some evidence that longer healing periods may not be required for consolidation of xenogenic bone grafts. However, clearly this time frame does not permit complete integration or resorption of the xenograft. The clinical procedures reflect this; intact xenograft particles were occasionally displaced from the healing tissue sites during the preparation of the osteotomy for implant placement. A longer healing period could favor further graft consolidation and improve the intraoperative experience for the clinician. However, it is noted that high implant survival and 5-year peri-implant tissue stability suggests that sufficient consolidation occurred prior to or continued following implant placement, provisionalization, and function.
The logistical and temporal advantages of immediate provisionalization 4 to 6 months following ridge augmentation merit consideration. First, a decision to avoid implant placement in a socket or insufficient alveolar ridge in favor of augmentation should always be made where needed. Second, the augmentation prior to implant placement simplifies the procedure and permits soft tissue closure at the time of grafting. Third, immediate provisionalization within the recently grafted site accelerates treatment with apparently little added risk of implant failure or soft tissue complication. This approach is temporally equivalent to early placement procedures that involve tooth extraction followed by early implant placement concurrent with buccal bone augmentation utilizing demineralized bone xenograft and a collagen membrane without implant provisionalization. 4 Both approaches involve at least a 6-month period of partial edentulism that is followed by implant placement and restoration. Comparing the 5-year outcomes from the early placement protocol to the present approach, both provide high implant survival and buccal tissue stability. The increased interproximal soft tissue (papilla) dimensions recorded here were not observed for the early loading protocol. While both procedures require mucoperiosteal reflection involving the adjacent teeth, in the present investigation, both flapped (n = 7) and flapless (n = 16) procedures resulted in positive interproximal tissue changes. The interproximal tissue differences are minor and may not influence the reportedly high esthetic values recorded. 27 However, the time of provisionalization as a variable merits further investigation in terms of peri-implant mucosal architecture.
The restorative protocol utilized a titanium abutment that was retained from provisionalization as the final abutment. This required the use of cement-retained provisional crowns. The perils of cementmediated inflammatory disease at implants, while identified nearly two decades ago by Walton and co-workers, 28 has become a recent prominent concern, although its impact remains debated. 29 The highest suspicion of cement retention must be adopted when cement-retained crowns are used for implant restorations. Every effort must be made to identify and remove excess cement. The present data set did not directly report on the occurrence of cement retention and removal, but the low incidence of inflammation (bleeding on probing) and absence of significant soft tissue complications suggest that efforts to control cement extrusion were carefully carried out. Although not adopted for this patient cohort, alveolar grafting can afford alternative implant orientation that favors screw retention, a therapeutic concept that offers several different advantages, including the elimination of cement from the protocol.
Conclusions
Alveolar bone augmentation required for implant placement within bound edentulous spaces can be performed using DBBM and a collagen membrane to create sufficient bone volume to permit subsequent implant placement and successful osseointegration. Alveolar ridge augmentation using DBBM and a collagen membrane supported the measured soft tissue architecture, including the buccal tissue levels, over a 5-year period. The immediate placement and provisionalization of implants into regenerated alveolar sites resulted in high implant survival and stability of both the interproximal papillae and buccal tissue architecture.
